U.S. Anti-Snoring Devices Market Size, Share, and Growth Forecast 2026–2033

The U.S. Anti-Snoring Devices Market is estimated at US$ 680.6 million in 2026 and is projected to reach US$ 1,023.4 million by 2033, expanding at a CAGR of 6.0% from 2026 to 2033. Market growth is supported by the rising prevalence of obstructive sleep apnea (OSA), habitual snoring, and other sleep-related breathing disorders, alongside increasing recognition of the impact of disrupted sleep on overall health and daily functioning. Growing consumer preference for non-invasive, convenient, and comfortable snoring management solutions is encouraging adoption of oral appliances, nasal devices, and other home-use products.

Product innovation is further strengthening market opportunities through improvements in device customization, fit, comfort, therapeutic effectiveness, and user experience. In addition, smart connectivity and integration with digital sleep-monitoring technologies are enhancing product functionality, enabling more personalized management, and supporting adoption across clinical practices, dental sleep medicine, retail channels, and direct-to-consumer markets. The expansion of e-commerce is also improving access to over-the-counter anti-snoring products and enabling consumers to compare and purchase devices more conveniently. Increasing collaboration between sleep specialists, dentists, and device manufacturers is further supporting awareness and adoption of clinically oriented anti-snoring solutions in the U.S. market.

Drivers - Rising Prevalence of Obstructive Sleep Apnea and Habitual Snoring in the U.S.

The increasing prevalence of obstructive sleep apnea (OSA), habitual snoring, and sleep-disordered breathing is a major factor supporting growth of the U.S. anti-snoring devices market. A large population of adults experiences persistent snoring, while growing recognition of the association between sleep-disordered breathing and cardiovascular health, daytime fatigue, impaired concentration, and reduced quality of life is encouraging individuals to seek treatment. Greater awareness among patients, primary-care physicians, sleep specialists, and dentists is also increasing demand for solutions that can be used outside traditional hospital settings.

This supports the adoption of mandibular advancement devices, tongue stabilizing devices, nasal devices, and other non-invasive products across the U.S. market. Increasing screening for sleep-related breathing disorders is also helping identify previously undiagnosed patients who may seek conservative approaches to symptom management. As awareness expands, snoring is increasingly viewed as a potential indicator of underlying sleep-related conditions rather than solely as a nighttime inconvenience, strengthening demand for dedicated management devices.

Growing Preference for Non-Invasive and Home-Based Sleep Solutions

U.S. consumers are increasingly seeking comfortable, convenient, and non-invasive alternatives for managing snoring and mild sleep-related breathing problems. Oral appliances and nasal devices can be used at home and generally require less complex handling than invasive interventions, making them attractive to consumers seeking practical nighttime solutions. The expansion of direct-to-consumer brands, retail availability, and online purchasing is further improving access to anti-snoring products.

In addition, increasing consumer interest in sleep quality, wellness, and personal health monitoring is encouraging individuals to address snoring earlier rather than treating it solely as a lifestyle inconvenience. These behavioral changes are expanding the addressable consumer base and supporting sustained demand in the U.S. market. Demand is particularly supported by consumers seeking portable solutions that can be incorporated into established bedtime routines without major changes to daily activities. The availability of multiple device formats and price points is also enabling consumers to select products based on comfort, severity of symptoms, and individual treatment preferences.

Increasing Role of Dental Sleep Medicine and Oral Appliance Therapy

The expanding role of dental sleep medicine is creating additional demand for oral anti-snoring devices in the U.S. Dentists trained in sleep medicine can contribute to the identification and management of patients requiring oral appliance therapy, particularly individuals who prefer alternatives to conventional positive airway pressure therapies. Customized and titratable mandibular advancement devices can provide improved fit and individualized positioning compared with basic over-the-counter products. Increasing collaboration between sleep physicians and dental professionals is therefore strengthening the clinical pathway for oral appliance-based treatment and supporting demand for professionally fitted anti-snoring devices. Advances in digital impressions, intraoral scanning, and computer-aided manufacturing are also improving the customization and production of oral appliances. This combination of clinical expertise and digital dentistry is expected to support wider acceptance of professionally fitted devices among U.S. patients seeking personalized treatment options.

Market Restraints

Device Discomfort and Inconsistent Long-Term Patient Adherence

Patient adherence remains an important constraint for the U.S. anti-snoring devices market. Some users experience jaw discomfort, tooth or gum irritation, excessive salivation, dry mouth, difficulty adjusting to the device, or changes in bite alignment, particularly during the initial adaptation period associated with oral appliances. These issues can result in intermittent use or treatment discontinuation, reducing the long-term effectiveness of devices and limiting repeat adoption. Comfort and fit are particularly important in a market where consumers can choose among multiple OTC and professionally fitted products. Manufacturers therefore face continued pressure to improve ergonomics, customization, material quality, and nighttime usability to strengthen treatment adherence. Adherence can also vary according to device design, individual anatomy, perceived treatment benefits, and the severity of snoring symptoms. Consequently, products that demonstrate measurable improvements in comfort and usability may gain a competitive advantage over standardized devices with limited customization.

Limited Reimbursement and Out-of-Pocket Costs for Certain Devices

Reimbursement considerations can restrict adoption of anti-snoring devices, particularly when products are purchased outside established clinical treatment pathways. While coverage may be available for certain medically indicated oral appliance therapies, coverage policies, eligibility requirements, and patient out-of-pocket costs can vary. Consumers purchasing OTC products may also bear the full cost themselves, making price an important consideration when choosing between basic nasal or oral products and customized clinical devices. This creates a two-tier market in which affordability supports volume sales of consumer products, while higher-priced customized appliances depend more heavily on clinical recommendations and perceived therapeutic value. High upfront costs for customized devices can therefore discourage price-sensitive consumers, particularly when the perceived benefits are limited to snoring reduction rather than treatment of a diagnosed condition. Greater transparency regarding clinical benefits, reimbursement eligibility, and total treatment costs could help reduce purchasing uncertainty and improve adoption.

Competition from Established Sleep Apnea Therapies

Anti-snoring devices compete with established approaches used to manage sleep-disordered breathing, particularly positive airway pressure therapies and other clinically established interventions. Patients diagnosed with moderate or severe OSA may require treatment beyond simple snoring-management products, limiting the addressable market for certain anti-snoring devices. In addition, consumers may perceive some OTC products as less clinically reliable than physician-recommended therapies. This distinction between snoring management and medically diagnosed OSA treatment can create adoption barriers and requires manufacturers to clearly communicate product indications and therapeutic positioning. Healthcare professionals may also prioritize evidence-based therapies for patients with clinically significant OSA, limiting the use of certain consumer-oriented products within medical settings. Manufacturers must therefore demonstrate appropriate clinical utility and clearly differentiate products intended for general snoring management from devices designed for diagnosed sleep-related breathing disorders.

Opportunities - Expansion of Smart and Digitally Connected Anti-Snoring Devices

The integration of sensors, mobile applications, sleep monitoring, artificial intelligence, and connected health platforms presents a significant opportunity in the U.S. anti-snoring devices market. Consumers are increasingly familiar with wearable and digital technologies that track sleep duration, movement, breathing patterns, and other nighttime parameters. Manufacturers can leverage this behavior by developing devices and companion applications capable of providing personalized feedback and monitoring changes in snoring patterns. Digital connectivity can also improve user engagement by helping consumers understand their sleep behavior and encouraging consistent device use. Over the longer term, integration with broader digital sleep-management ecosystems could create additional opportunities for product differentiation and recurring software-based revenue. AI-enabled analytics could further support individualized recommendations by identifying changes in snoring frequency, sleep patterns, or device usage over time. Integration with smartphones, smartwatches, and other connected health devices could also create a more comprehensive digital environment for monitoring and managing sleep-related concerns.

Growing Demand for Personalized and Professionally Fitted Oral Appliances

The increasing preference for customized treatment solutions represents another important opportunity in the U.S. market. Professionally fitted mandibular advancement devices can be adjusted according to individual anatomy, comfort requirements, and therapeutic response, providing an advantage over standardized consumer products. Advances in digital dentistry, intraoral scanning, computer-aided design, and manufacturing are also enabling more efficient development of customized oral appliances.

As patients become more aware of the differences between generic and professionally fitted devices, manufacturers and dental practices can capitalize on demand for personalized solutions with improved comfort, fit, and usability. Digital workflows can shorten appliance development cycles while enabling more precise fitting and iterative adjustments based on patient feedback. These capabilities are expected to strengthen the position of customized oral appliances within dental sleep medicine and create opportunities for premium product offerings in the U.S. market.

Expansion of E-Commerce and Direct-to-Consumer Distribution

The continued expansion of e-commerce and direct-to-consumer distribution is creating opportunities for anti-snoring device manufacturers to reach consumers beyond traditional pharmacies and clinical settings. Online platforms allow consumers to compare product features, prices, customer reviews, and usage instructions before purchasing. This channel is particularly relevant for nasal devices, chin straps, entry-level oral appliances, and other OTC products. Manufacturers can further strengthen online sales through educational content, digital screening tools, subscription-based replacement programs, and mobile applications. As a result, e-commerce is expected to remain an important channel for expanding product accessibility and increasing consumer awareness of available snoring-management solutions. Online distribution also enables manufacturers to reach consumers in geographically underserved areas where specialized sleep or dental practices may be less accessible. In addition, digital marketing and personalized product recommendations can help companies target specific consumer groups based on symptoms, product preferences, and purchasing behavior, supporting higher conversion and repeat sales.

Product Type Analysis

Mandibular Advancement Devices (MADs) represent the leading product category in the U.S. anti-snoring devices market, accounting for 43.7% of market revenue in 2026. These oral appliances work by repositioning the lower jaw forward during sleep, helping maintain upper-airway patency and reducing airway-related vibration associated with snoring. Their strong market position is supported by established clinical use in patients with snoring and selected cases of mild-to-moderate obstructive sleep apnea, particularly among individuals seeking alternatives to positive airway pressure therapy.

The U.S. market includes both professionally fitted, titratable appliances and consumer-oriented boil-and-bite products, allowing manufacturers to address different price points and treatment preferences. Increasing adoption of digitally designed, customized, and 3D-manufactured oral appliances is further improving fit and comfort while supporting premium pricing. Continued innovation in materials, adjustability, and patient-specific design is expected to sustain MADs as the dominant product category through the forecast period.

Patient Type Analysis

Adults represent the dominant patient group in the U.S. anti-snoring devices market, accounting for 72.8% of market revenue in 2026. The segment encompasses a broad population experiencing habitual snoring and sleep-related breathing disturbances, with demand influenced by factors such as age, body weight, alcohol consumption, sleep patterns, and upper-airway characteristics. Working-age adults also represent an important commercial demographic because of their greater exposure to digital health information, e-commerce platforms, and consumer wellness products.

Increasing awareness of the relationship between poor sleep, daytime fatigue, concentration, and overall health is encouraging more adults to actively seek solutions for persistent snoring. In addition, the availability of OTC products through online retailers and pharmacies enables consumers to address snoring without immediately entering a specialized clinical treatment pathway. Growing interest in sleep optimization, wearable monitoring, and home-based healthcare is expected to further support device adoption among U.S. adults.

Distribution Channel Analysis

E-commerce represents the leading distribution channel in the U.S. anti-snoring devices market, accounting for 38.8% of market revenue in 2026. The channel has gained importance as consumers increasingly research sleep-related concerns online and seek convenient access to OTC anti-snoring products, including nasal devices, chin straps, and entry-level oral appliances. Online platforms provide consumers with broader product selection, pricing comparisons, customer reviews, educational information, and home delivery, reducing barriers associated with purchasing specialized sleep products.

Retail pharmacies remain an important channel because of their extensive physical presence and established consumer trust, particularly for first-time purchasers seeking readily available OTC solutions. Hospitals and clinics continue to play a critical role in the professional segment, particularly for customized oral appliances recommended through sleep medicine and dental practices. The continued convergence of digital health, direct-to-consumer marketing, and online purchasing is expected to strengthen e-commerce penetration throughout the forecast period.

Southeast U.S. Anti-Snoring Devices Market Trends and Insights

The Southeast U.S. is estimated to represent the leading regional market for anti-snoring devices in 2026, supported by its large and diverse population base, substantial adult and aging demographic, and significant demand for sleep-related healthcare services. The region's prevalence of risk factors associated with snoring and obstructive sleep apnea, including obesity and other lifestyle-related conditions, creates a sizeable addressable population for anti-snoring products. Growing awareness of sleep health is encouraging consumers to seek non-invasive solutions such as mandibular advancement devices, nasal devices, and tongue stabilizing devices.

The expanding presence of healthcare providers, pharmacies, dental practices, and online retailers is also improving product accessibility. Increasing consumer interest in home-based sleep management and digitally enabled wellness solutions is expected to further support demand across the Southeast. The region also provides manufacturers with opportunities to expand through pharmacy-based and direct-to-consumer channels, particularly for OTC products. Increasing engagement with preventive healthcare and sleep wellness is expected to encourage earlier consideration of snoring-management products among consumers.

Southwest U.S. Anti-Snoring Devices Market Trends and Insights

The Southwest U.S. is expected to register the fastest growth in the U.S. anti-snoring devices market during the forecast period. Population expansion in major metropolitan areas, increasing healthcare utilization, and rising awareness of sleep-disordered breathing are creating favorable conditions for market development. Consumers are showing growing interest in convenient products that can be used at home, particularly OTC nasal devices, oral appliances, and other non-invasive solutions.

In addition, strong digital adoption and the growing use of e-commerce platforms are enabling manufacturers to reach consumers directly, supporting faster product penetration throughout the region. Growing healthcare infrastructure in expanding urban centers is expected to improve access to sleep diagnostics and specialist consultations. The combination of population growth, digital purchasing behavior, and increasing awareness of sleep quality provides a favorable environment for new product launches and market expansion.

West U.S. Anti-Snoring Devices Market Trends and Insights

The West U.S. represents an important market for anti-snoring devices due to high consumer awareness of preventive healthcare, strong adoption of digital health technologies, and established interest in sleep and wellness products. Consumers in the region demonstrate increasing willingness to invest in personalized healthcare solutions, creating opportunities for premium and technologically advanced anti-snoring devices. The presence of specialized healthcare providers, dental practices, technology-oriented companies, and established e-commerce infrastructure further supports market development.

Demand is particularly supported by increasing interest in smart sleep monitoring, connected applications, customized oral appliances, and personalized sleep-management solutions. Continued integration of digital technologies into healthcare is expected to strengthen the region's adoption of advanced anti-snoring products. The region's technology-oriented consumer base also provides favorable conditions for connected anti-snoring devices that combine physical therapy with digital monitoring capabilities. Manufacturers offering app-enabled products, data-driven feedback, and improved personalization can therefore find strong opportunities for differentiation in the West.

Northeast U.S. Anti-Snoring Devices Market Trends and Insights

The Northeast U.S. maintains a significant position in the U.S. anti-snoring devices market, supported by its concentration of healthcare institutions, sleep centers, dental practices, and specialized medical professionals. High healthcare awareness and access to diagnostic services encourage consumers to seek professional evaluation for persistent snoring and suspected sleep-disordered breathing. The region also benefits from established clinical pathways for oral appliance therapy and strong availability of medically oriented anti-snoring products. Increasing collaboration between sleep physicians and dental professionals is supporting the use of customized mandibular advancement devices among appropriate patients.

Furthermore, rising consumer interest in sleep quality and preventive health is creating additional demand for OTC and digitally enabled anti-snoring solutions. The concentration of specialized healthcare providers also supports greater awareness of clinically appropriate treatment options and professionally fitted oral appliances. As digital consultations and remote monitoring become more established, patients across the region may gain additional flexibility in accessing sleep-related services and follow-up care.

Midwest U.S. Anti-Snoring Devices Market Trends and Insights

The Midwest U.S. presents steady growth opportunities for anti-snoring device manufacturers, supported by its substantial population base and increasing recognition of sleep-related health conditions. Demand is being strengthened by growing awareness of obstructive sleep apnea, habitual snoring, and the broader health consequences of inadequate sleep. Pharmacies, healthcare facilities, dental practices, and e-commerce platforms provide multiple channels through which consumers can access anti-snoring products. While adoption of advanced customized devices is concentrated around major healthcare markets, online distribution is helping extend product availability to consumers in less densely served areas.

Increasing adoption of telehealth consultations and home-based health monitoring is also improving access to sleep-related guidance, creating additional opportunities for anti-snoring device penetration across the region. Greater availability of online educational resources can further encourage consumers to recognize persistent snoring as a potential sleep-health concern and explore available treatment options. Expansion of pharmacy networks and digital healthcare services is also expected to improve product accessibility across smaller cities and suburban communities.

The U.S. Anti-Snoring Devices Market exhibits a moderately fragmented competitive structure, with established medical device companies, specialized oral appliance manufacturers, dental sleep medicine providers, and emerging sleep-technology companies competing across clinical, OTC, and direct-to-consumer segments. ResMed Inc., SomnoMed Limited, ProSomnus Sleep Technologies, Inc., Vivos Therapeutics, Inc., and Koninklijke Philips N.V. are among the notable companies participating in the broader U.S. sleep and anti-snoring device landscape. Competition is increasingly centered on customized oral appliance design, improved patient comfort, clinical validation, digital sleep monitoring, professional dental partnerships, and direct-to-consumer distribution. Companies are also investing in advanced materials, digital manufacturing, sensor-enabled technologies, and personalized treatment approaches to improve device performance and patient adherence. Expanding e-commerce networks and collaborations with sleep specialists and dental professionals are further enabling market participants to strengthen brand visibility and expand their reach across the U.S.

Key Developments:

• In June 2026, Eli Lilly launched a national sleep apnea awareness campaign featuring Shaquille O’Neal and Zepbound to increase awareness of sleep apnea and promote understanding of available treatment options. The initiative aims to encourage earlier recognition of sleep-related breathing disorders and highlight the importance of effective management approaches.
• In October 2025, Smartee Denti-Technology launched Smartee Sleep Aligners, a clear aligner-based solution designed for managing obstructive sleep apnea hypopnea syndrome (OSAHS) and primary snoring. The product range includes Smartee SA and Smartee SA Plus, offering clinicians a discreet, comfortable alternative to conventional therapies while improving patient compliance and sleep quality.